These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35717429)

  • 61. A Real-world Multicenter Prospective Study of Everolimus in Pancreatic Neuroendocrine Tumors: The 'PROTOR' Study.
    Kaltsas G; Andreadis C; Kosmidis P; Mavroudis D; Pazaitou-Panayiotou K; Vaslamatzis M; Athanasiadis I
    Anticancer Res; 2022 Apr; 42(4):1941-1948. PubMed ID: 35347014
    [TBL] [Abstract][Full Text] [Related]  

  • 62.
    Mapelli P; Bezzi C; Palumbo D; Canevari C; Ghezzo S; Samanes Gajate AM; Catalfamo B; Messina A; Presotto L; Guarnaccia A; Bettinardi V; Muffatti F; Andreasi V; Schiavo Lena M; Gianolli L; Partelli S; Falconi M; Scifo P; De Cobelli F; Picchio M
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2352-2363. PubMed ID: 35156146
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
    Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
    Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
    Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
    Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preoperative prediction for lauren type of gastric cancer: A radiomics nomogram analysis based on CT images and clinical features.
    Sun Z; Jin L; Zhang S; Duan S; Xing W; Hu S
    J Xray Sci Technol; 2021; 29(4):675-686. PubMed ID: 34024809
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact.
    Jiang Y; Che S; Ma S; Liu X; Guo Y; Liu A; Li G; Li Z
    Cancer Imaging; 2021 Jan; 21(1):1. PubMed ID: 33407884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 18F-FDG and 18F-FLT-PET imaging for monitoring everolimus effect on tumor-growth in neuroendocrine tumors: studies in human tumor xenografts in mice.
    Johnbeck CB; Munk Jensen M; Haagen Nielsen C; Fisker Hag AM; Knigge U; Kjaer A
    PLoS One; 2014; 9(3):e91387. PubMed ID: 24626055
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predicting symptomatic mesenteric mass in small intestinal neuroendocrine tumors using radiomics.
    Blazevic A; Starmans MPA; Brabander T; Dwarkasing RS; van Gils RAH; Hofland J; Franssen GJH; Feelders RA; Niessen WJ; Klein S; de Herder WW
    Endocr Relat Cancer; 2021 Jun; 28(8):529-539. PubMed ID: 34003139
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study.
    Fan S; Li X; Cui X; Zheng L; Ren X; Ma W; Ye Z
    Acad Radiol; 2019 Dec; 26(12):1633-1640. PubMed ID: 30929999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Integrating CT-based radiomic model with clinical features improves long-term prognostication in high-risk prostate cancer.
    Ching JCF; Lam S; Lam CCH; Lui AOY; Kwong JCK; Lo AYH; Chan JWH; Cai J; Leung WS; Lee SWY
    Front Oncol; 2023; 13():1060687. PubMed ID: 37205204
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
    Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
    Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With
    Tang X; Li Y; Yan WF; Qian WL; Pang T; Gong YL; Yang ZG
    Front Oncol; 2021; 11():719919. PubMed ID: 34660285
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Radiomic biomarkers from chest computed tomography are assistive in immunotherapy response prediction for non-small cell lung cancer.
    Schroeder KE; Acharya L; Mani H; Furqan M; Sieren JC
    Transl Lung Cancer Res; 2023 May; 12(5):1023-1033. PubMed ID: 37323179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?
    Luo Y; Chen J; Shen B; Wang M; Cai H; Xu L; Chen L; Chen M; Li ZP; Feng ST
    Eur Radiol; 2018 Dec; 28(12):5250-5257. PubMed ID: 29876704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.
    Fiz F; Masci C; Costa G; Sollini M; Chiti A; Ieva F; Torzilli G; Viganò L
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3387-3400. PubMed ID: 35347437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. mTOR-inhibitor treatment of metastatic renal cell carcinoma: contribution of Choi and modified Choi criteria assessed in 2D or 3D to evaluate tumor response.
    Lamuraglia M; Raslan S; Elaidi R; Oudard S; Escudier B; Slimane K; Penna RR; Wagner M; Lucidarme O
    Eur Radiol; 2016 Jan; 26(1):278-85. PubMed ID: 25953002
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.